BIOTYPE GmbH
Contact Person
Company / Organization
1999
FoundersDr. Wilhelm Zörgiebel, Prof. Jörg Gabert, Dr. Peter Dobrowolski
OwnerMolecular Diagnostics Group GmbH
ManagementTimm Zörgiebel (CEO), Dr. Felix Zörgiebel (CTO), Dr. Kerstin Korn (COO), Dr. Manja Böhme (CCO), Rico Wünsche (CFO)
In vitro diagnostics, molecular diagnostics, molecular genetic test systems, molecular precision diagnostics, DNA & RNA analytics, contract development of molecular genetic tests (RUO, IUO, IVD), contract manufacturing of molecular genetic tests (RUO, IUO, IVD).
employees80
export contentapprox 50%
Sales marketworldwide
BIOTYPE is an innovative solution provider for molecular precision diagnostics. Our products and services support the reliable detection and interpretation of biomarker signatures for translational research and clinical diagnostics in precision medicine. BIOTYPE offers a strong portfolio in the field of molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and the molecular characterization of solid tumors. The portfolio includes in vitro diagnostic (IVD) tests for clinical diagnostics and research-use-only (RUO) tests for translational and clinical research. Furthermore, BIOTYPE offers high-quality, IVD-compliant contract development and contract manufacturing services. Our proprietary MODAPLEX platform is a benchtop device for the automated detection and evaluation of molecular profiles and molecular genetic multiparameter tests (multi-gene tests & multiplex applications).
At BIOTYPE, we believe that the management and treatment of complex diseases can be dramatically improved through greater access to precision diagnostics. With our molecular testing systems, we offer integrated workflow solutions that enable our customers to obtain reliable results within one business day, reduce staff commitment to equipment, and automate data analysis.
BIOTYPE's processes, products, and services meet the highest quality standards, as we are certified according to DIN EN ISO 13485 and DIN EN ISO 9001. BIOTYPE GmbH, a molecular genetic diagnostics company, is part of the Molecular Diagnostics Group (MDG), which develops holistic solutions for precision medicine.